Professor | Daming Zhou | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Daming Zhou
Contact Information	daming.zhou@zju.edu.cn
Language ability	English, Chinese
Province	Zhejiang

Upload Avatar (500 x 500)

Name

Daming Zhou

Contact Information

daming.zhou@zju.edu.cn

Language ability

English, Chinese

Province

Zhejiang

University/Lab Affiliation and Title	Zhejiang University
Faculty	Life Sciences
Academic Background & Achievements	2009-2013 Bachelor in Biotechnology: Nankai University 2015-2020 PhD in Clinical Medicine: University of Oxford 2023 National Overseas High-level Talents
Work Experience	2013-2014 Research Assistant: Tianjin Protein Key Laboratory 2015 Assistant Researcher: Chengdu Pioneer Pharmaceutical Co., Ltd 2020-2023 Postdoctoral Researcher: Department of Structural Biology, University of Oxford 2024-Present Researcher: Zhejiang University, School of Life Sciences
Awards	2023 Award for Excellent Scheme, University of Oxford 2022 Horizon Prize for the Oxford nanobody team, Royal Society of Chemistry, UK 2021 Recognition Scheme Award for research on COVID, University of Oxford

University/Lab Affiliation and Title

Zhejiang University

Faculty

Life Sciences

Academic Background & Achievements

2009-2013 Bachelor in Biotechnology: Nankai University
2015-2020 PhD in Clinical Medicine: University of Oxford
2023 National Overseas High-level Talents

Work Experience

2013-2014 Research Assistant: Tianjin Protein Key Laboratory
2015 Assistant Researcher: Chengdu Pioneer Pharmaceutical Co., Ltd
2020-2023 Postdoctoral Researcher: Department of Structural Biology, University of Oxford
2024-Present Researcher: Zhejiang University, School of Life Sciences

Awards

2023 Award for Excellent Scheme, University of Oxford
2022 Horizon Prize for the Oxford nanobody team, Royal Society of Chemistry, UK
2021 Recognition Scheme Award for research on COVID, University of Oxford

Areas of Focus	Viral and host interaction mechanisms Development of antiviral drugs
Publications	Rapid escape of new SARS-CoV-2 Omicron variants from BA. 2-directed antibody responses, Dijokaite-Guraliuc, A., Das, R., Zhou, D., Ginn, H. M., Liu, C., Duyvesteyn, H. M., ... & Screaton, G. R., 2023 Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum, Tuekprakhon, A., Nutalai, R., Dijokaite-Guraliuc, A., Zhou D., Ginn, H. M., Selvaraj, M., ... & Screaton, G. R., 2022 Potent cross-reactive antibodies following Omicron breakthrough in vaccinees, Nutalai, R., Zhou D., Tuekprakhon, A., Ginn, H. M., Supasa, P., Liu, C., ... & Screaton, G. R., 2022 SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses, Dejnirattisai W., Huo J., Zhou D., Zahradník J., Supasa P., Liu C., ... & Screaton G. R., 2022 Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2, Huang K. Y. A., Zhou D., Tan T. K., Chen C., Duyvesteyn H. M. E., Zhao Y., ... & Stuart D. I., 2022 The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants, Liu C., Zhou D., Nutalai R., Duyvesteyn H. M. E., Tuekprakhon A., Ginn H. M., ... & Screaton G. R., 2021 Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum, Liu C., Ginn H. M., Dejnirattisai W., Supasa P., Wang B., Tuekprakhon A., Nutalai R., Zhou D., ... & Screaton G. R., 2021 Antibody evasion by the P.1 strain of SARS-CoV-2, Dejnirattisai W., Zhou D., Supasa P., Liu C., Mentzer A. J., Ginn H. M., ... & Screaton G. R., 2021 Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, Zhou D., Dejnirattisai W., Supasa P., Liu C., Mentzer A. J., Ginn H. M., ... & Screaton G. R., 2021 Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera, Supasa P., Zhou D., Dejnirattisai W., Liu C., Mentzer A. J., Ginn H. M., ... & Screaton G. R., 2021 The antigenic anatomy of SARS-CoV-2 receptor binding domain, Dejnirattisai W., Zhou D., Ginn H. M., Duyvesteyn H. M., Supasa P., Case J. B., ... & Screaton G. R., 2021 Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71, Huang K. Y. A., Zhou D., Fry E. E., Kotecha A., Huang P. N., Yang S. L., ... & Stuart D. I., 2020 Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient, Zhou D., Duyvesteyn H. M., Chen C. P., Huang C. G., Chen T. H., Shih S. R., ... & Huang K. Y. A., 2020 Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10, Zhao Y., Zhou D., Ni T., Karia D., Kotecha A., Wang X., ... & Stuart D. I., 2020 Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2, Zhou D.*, Zhao Y., Kotecha A., Fry E. E., Kelly J. T., Wang X., ... & Stuart D. I., 2018

Areas of Focus

Viral and host interaction mechanisms
Development of antiviral drugs

Publications

Rapid escape of new SARS-CoV-2 Omicron variants from BA. 2-directed antibody responses, Dijokaite-Guraliuc, A., Das, R., Zhou, D.*, Ginn, H. M., Liu, C., Duyvesteyn, H. M., ... & Screaton, G. R., 2023
Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum, Tuekprakhon, A., Nutalai, R., Dijokaite-Guraliuc, A., Zhou D.*, Ginn, H. M., Selvaraj, M., ... & Screaton, G. R., 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees, Nutalai, R., Zhou D.*, Tuekprakhon, A., Ginn, H. M., Supasa, P., Liu, C., ... & Screaton, G. R., 2022
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses, Dejnirattisai W., Huo J., Zhou D.*, Zahradník J., Supasa P., Liu C., ... & Screaton G. R., 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2, Huang K. Y. A., Zhou D.*, Tan T. K., Chen C., Duyvesteyn H. M. E., Zhao Y., ... & Stuart D. I., 2022
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants, Liu C., Zhou D.*, Nutalai R., Duyvesteyn H. M. E., Tuekprakhon A., Ginn H. M., ... & Screaton G. R., 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum, Liu C., Ginn H. M., Dejnirattisai W., Supasa P., Wang B., Tuekprakhon A., Nutalai R., Zhou D.*, ... & Screaton G. R., 2021
Antibody evasion by the P.1 strain of SARS-CoV-2, Dejnirattisai W., Zhou D.*, Supasa P., Liu C., Mentzer A. J., Ginn H. M., ... & Screaton G. R., 2021
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, Zhou D.*, Dejnirattisai W., Supasa P., Liu C., Mentzer A. J., Ginn H. M., ... & Screaton G. R., 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera, Supasa P., Zhou D.*, Dejnirattisai W., Liu C., Mentzer A. J., Ginn H. M., ... & Screaton G. R., 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domain, Dejnirattisai W., Zhou D.*, Ginn H. M., Duyvesteyn H. M., Supasa P., Case J. B., ... & Screaton G. R., 2021
Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71, Huang K. Y. A., Zhou D.*, Fry E. E., Kotecha A., Huang P. N., Yang S. L., ... & Stuart D. I., 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient, Zhou D.*, Duyvesteyn H. M., Chen C. P., Huang C. G., Chen T. H., Shih S. R., ... & Huang K. Y. A., 2020
Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10, Zhao Y., Zhou D.*, Ni T., Karia D., Kotecha A., Wang X., ... & Stuart D. I., 2020
Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2, Zhou D.*, Zhao Y., Kotecha A., Fry E. E., Kelly J. T., Wang X., ... & Stuart D. I., 2018

Virology Host Interaction Mechanisms Antiviral Drug Development Biochemistry Structural Biology Molecular Biology Therapeutics Pathogens

Lizeng Gao - University of Chinese Academy of Sciences

Yujie Ren - University of Chinese Academy of Sciences

Xiao Gengfu - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us